Opposite effects of a beta-adrenergic agonist and a phosphodiesterase inhibitor on glucose transport in isolated human adipocytes: isoproterenol increases Vmax and IBMX increases Ks.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology*; D019325:3-O-Methylglucose; D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D001693:Biological Transport, Active / Q000187:drug effects; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology*; D007700:Kinetics; D008066:Lipolysis / Q000187:drug effects*; D008297:Male; D008757:Methylglucosides / Q000378:metabolism*; D008759:Methylglycosides / Q000378:metabolism*; D011433:Propranolol / Q000494:pharmacology; D013806:Theophylline / Q000031:analogs & derivatives*
D008757:Methylglucosides; D008759:Methylglycosides; D019325:3-O-Methylglucose; D011433:Propranolol; D013806:Theophylline; D007545:Isoproterenol; D015056:1-Methyl-3-isobutylxanthine